Organigram Global (NASDAQ: OGI) sets Q3 2026 earnings call for Aug. 11
Rhea-AI Filing Summary
Organigram Global Inc. will report earnings results for its third quarter ended June 30, 2026 on Tuesday, August 11, 2026, prior to market open. The company will host a conference call at 8:00 am Eastern Time, with registration and webcast access provided via online links and a replay available within 24 hours for 90 days.
Organigram is described as Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH. It operates cultivation, processing and edibles facilities in New Brunswick, Quebec, Manitoba and Southwestern Ontario, and markets multiple cannabis brands in Canada and Europe under Health Canada regulation.
Positive
- None.
Negative
- None.
Key Figures
Earnings release date: August 11, 2026
Quarter end date: June 30, 2026
Conference call time: 8:00 am Eastern Time
+2 more
5 metrics
Earnings release date
August 11, 2026
Date for reporting third quarter fiscal 2026 results
Quarter end date
June 30, 2026
Fiscal third quarter ended June 30, 2026
Conference call time
8:00 am Eastern Time
Scheduled start time for the Q3 2026 earnings call
Webcast replay period
90 days
Replay of the earnings webcast archived following the call
Processing facilities in Southwestern Ontario
2 facilities
Cannabis processing facilities located in Aylmer and London
Key Terms
foreign private issuer, Cannabis Act, forward-looking information, annual information form, +1 more
5 terms
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Cannabis Act regulatory
"The Company is regulated by Health Canada under the Cannabis Act"
A cannabis act is a government law that creates the rules for producing, selling, using, and regulating cannabis products in a given jurisdiction. Think of it like the traffic code for a new industry: it sets who can operate, what safety and labeling standards must be met, and how taxes and licenses are handled — all of which directly affect companies’ costs, revenue potential, and legal risks, so investors watch changes closely.
forward-looking information regulatory
"This news release contains forward-looking information."
Forward-looking information are predictions, plans, estimates or expectations about a company’s future performance, results or events, such as sales forecasts, project timelines, or anticipated costs. It matters to investors because these statements guide expectations but rely on assumptions and uncertain factors—like a weather forecast for a business—so investors should treat them as informed guesses rather than guarantees and consider the risks and possible changes behind the numbers.
annual information form financial
"factors and risks disclosed in the Company’s most recent annual information form"
A company's annual information form is a comprehensive regulatory filing that lays out its business description, key assets, risks, legal matters and other background details shareholders need to understand the company’s operations. Think of it as a detailed owner’s manual or dossier that supplements financial statements, helping investors do deeper homework on how the business works and what could affect its future performance.
management’s discussion and analysis financial
"annual information form, management’s discussion and analysis, and other Company documents"
Management’s discussion and analysis (MD&A) is a narrative section of a company’s financial filing where executives explain the recent financial results, underlying causes of those results, trends they see, and material risks and uncertainties in everyday language. Investors rely on it like a company’s report card with the manager’s comments—helping interpret raw numbers, judge future prospects and cash needs, and spot warnings or opportunities that the financial statements alone may not reveal.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
When will Organigram Global (OGI) release its Q3 fiscal 2026 results?
Organigram Global will release its third quarter fiscal 2026 results on Tuesday, August 11, 2026, before market open. The results cover the quarter ended June 30, 2026 and will be accompanied by a management conference call and webcast.
What time is Organigram Global (OGI) holding its Q3 2026 earnings call?
The Q3 2026 earnings conference call is scheduled for 8:00 am Eastern Time on August 11, 2026. Participants can register online to receive dial-in details and unique access codes, and can also access a concurrent webcast through the company's event link.
How can investors access the Organigram Global (OGI) Q3 2026 earnings webcast and replay?
Investors can access the Q3 2026 webcast via an online attendee link provided by Organigram. A replay will be available within 24 hours after the call at the company's investor website and will remain archived for 90 days.
What markets and brands does Organigram Global (OGI) participate in?
Organigram participates in the Canadian adult-use and European medical cannabis markets, including Germany through its acquisition of Sanity Group. It manages brands such as Edison, SHRED, Monjour, BOXHOT, DEBUNK and several European brands including Vayamed and VAAY.
Where are Organigram Global's (OGI) production and processing facilities located?
Organigram operates facilities in Moncton, New Brunswick and Lac Supérieur, Quebec, plus an edibles facility in Winnipeg, Manitoba. It also runs two cannabis processing facilities in Southwestern Ontario, located in Aylmer and London for extraction, processing, packaging and fulfillment.
Under what regulations does Organigram Global (OGI) operate its cannabis business?
Organigram operates under Health Canada oversight pursuant to the Cannabis Act and the Cannabis Regulations. These federal regulations govern cultivation, processing and sale of cannabis products across Canada for both adult-use and medical markets.